Skip to content

Clinical trials

Phase 2 Communicable Diseases trials

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Communicable Diseases Phase: Phase 2 Clear all

46 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20021
20051
20062
20102
20131
20153
20163
20172
20191
20203
20212
20224
20233
20242
20252
20263

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed26
Terminated6
Recruiting5
Unknown status5
Active, not recruiting2
Not yet recruiting1
Withdrawn1

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
National Center for Research Resources (NCRR)6
National Institute of Allergy and Infectious Diseases (NIAID)3
101 Therapeutics2
AusperBio Therapeutics Inc.2
Lisa Flowers2
Vanderbilt University Medical Center2
60 Degrees Pharmaceuticals LLC1
60P Australia Pty Ltd1
Ain Shams University1
Astellas Pharma Inc1

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Communicable Diseases46
Immune System Diseases10
Rare Diseases10
Infections9
Virus Diseases5
COVID-194
Influenza, Human4
Arthritis3
Bacterial Infections3
Connective Tissue Diseases3

Trials

Showing 26 to 46 of 46. Each trial links to its page on Pharma Observatory.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.